Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Spanish Study Identifies 5 Skin Manifestations in COVID-19 Patients

IPC FELLOW DR. ROMINA CONTRERAS TALKS WITH CO-AUTHOR DR. ALBA CATALÀ ABOUT THE STUDY AND HOW IT CONTRIBUTES TO A GROWING UNDERSTANDING OF THE NOVEL CORONAVIRUS

The cutaneous manifestations in patients with different severities of COVID-19, as well as cutaneous lesions in those with mild symptoms or asymptomatic disease, sparked the interest of a group of Spanish researchers led by Dr. Alba Català and Dr. Cristina Galván. The investigators decided to conduct a study that would characterize these lesions and relate them to other clinical findings.

The study, conducted from 3 to 16 April 2020, described 5 major clinical patterns. This classification of the cutaneous manifestations of COVID-19 has helped to improve the understanding of disease severity and the temporal relationship (the different times and durations that lesions appear) during the course of the infection. It is the first study to classify COVID-19-associated skin lesions and provide an atlas of images of them.

In a videoconference interview (one of the many activities incorporated in our new way of living with the COVID-19 virus that allows us to stay close despite our distances), Dr. Català discussed her research.

Dr Català, a Spanish dermatologist, is an associate professor at Hospital Plató in Barcelona. She is one of the main authors of the COVID-19 study. A Spanish version of the study, entitled “COVID-19 y piel/COVID-19 and the Skin,” was published in the Spanish journal Actas Dermo-Sifiliográficas.1 An English version, entitled “Classification of cutaneous manifestations of COVID-19: A rapid prospective nationwide consensus study in Spain with 375 cases,” was published in the British Journal of Dermatology.2

Dr Català said the idea for this study was initiated by chance. She and Dr. Galván, a dermatologist at the Hospital Universitario de Móstoles, Madrid, met when each of them joined an online dermatology chat group to gather as much information as possible about this novel virus. At the time in March 2020, information about COVID-19 and skin symptoms was scarce.

One of the doctors participating in the chat presented the case of a COVID-19 patient with a skin rash and no other symptoms to see if other participants had patients with similar clinical findings. Drs. Català and Galván exchanged ideas and decided to collect information about cases that were flooding social networks. Eager to contribute to the understanding of COVID-19, especially its skin manifestations, they decided to conduct a national study. Their goal was to characterize the skin manifestations associated with the disease and investigate their possible diagnostic, prognostic, and epidemiological value.

The study protocol was designed in conjunction with Dr. Gregorio Carretero, a Spanish dermatologist at the Hospital Universitario de Gran Canaria. It began after approvals by an ethics committee and the Spanish Drug Agency.

With the help of the Spanish Academy of Dermatology and Venereology (AEDV), the researchers requested the collaboration of all Spanish dermatologists. Taking into account the high workload imposed on these doctors, many of whom were reassigned to the acute care of patients with COVID-19, they designed a simple online questionnaire.

Initially, their objective was to collect at least 60 cases in a span of 2 weeks during the peak of the pandemic. Due to the extensive participation of their colleagues, they obtained 120 cases by the middle of the recruitment period. By the end of the 2 weeks, they had collected 430 cases, 375 of which were entered into the study.

Drs. Català and Galván were also assisted by the research unit of AEDV’s Piel Sana Foundation, which was responsible for technical support, guidance, and statistical analysis, and for ensuring good research practices. The AEDV publicized the study through social networks and the media reported on it as well. The publicity prompted patients to ask their doctors to be included in the study.

More than 100 dermatologists from hospitals, private centers, and outpatient clinics across Spain participated in the study. Dr. Català credited the “solidarity” of these colleagues as well as that of COVID-19 patients who were willing to participate in the study for its completion and national distribution. All of the participants, she said, were eager to help understand more about this new disease.

For her part, Dr. Català said the study has reinforced her own research skills and helped her learn more about COVID-19. The study’s worldwide distribution has given her the satisfaction of having contributed to the knowledge about this challenging disease.

Another lesson from this national, collaborative study: Its completion in such a short time and during a time of so much adversity shows that joint effort and teamwork are key to achieving extraordinary results.

Dr. Contreras is a 2019 IPC Fellow who specializes in dermatology and venereology. She holds clinic and teaches at the Hospital de Clinicas Department of Dermatology in Asunción, Paraguay. Her special interest is the integral management of psoriasis, combining clinical practice and research.

REFERENCES

1. Català Gonzalo A, Galván Casas C. COVID-19 y piel. COVID-19 and the Skin. Actas Dermosifiliogr. 2020;S0001-7310(20)30131-9. https://doi.org/10.1016/j.ad.2020.04.007

2. Casas CG, Català A, Hernández GC, Rodríguez‐Jiménez P, Fernández‐Nieto D, Lario AR-V, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. https://doi.org/10.1111 bjd.19163

Categories

Recent Posts

FDA Labeling Now Aligns with the IPC and NPF Joint Position Statement on Tuberculosis Testing

Dose Reduction of IL-17 and IL-23 Inhibitors: Are We Ready for Tailored Dosing in the Era of Disease Modification?

Remembering Dr. Craig Leonardi

Also Read

Psoriasis

Psoriasis and the Pandemic: Lessons Learned from PsoProtect

The spread of COVID-19 in early 2020 brought many concerns and questions about COVID-19 and psoriasis. To help address these concerns dermatologists and researchers created PsoProtect and PsoProtectMe — two global registries aimed at understanding the impact of the pandemic on people with psoriasis. Co-directors of PsoProtect and PsoProtectMe, Catherine Smith and Satveer Mahil, speak about the data collection process and findings from these global registries.

Read More

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

What's New

Remembering Dr. Craig Leonardi

The International Psoriasis Council (IPC) remembers Dr. Craig Leonardi, founding member and former President, whose research shaped modern psoriasis treatment.

Read More »

Look Beyond My Skin: World Psoriasis Day 2026

World Psoriasis Day, observed each year on October 29, was launched by the International Federation of Psoriasis Associations (IFPA) in 2004 to give a voice to the more than 125 million people worldwide living with psoriasis and psoriatic arthritis. To mark this year’s observance, IPC joined the Latin American Society of Psoriasis and Dermoimmunology (SOLAPSO) and the Skin Inflammation and Psoriasis International Network (SPIN) to create a video series around the theme “Look Beyond My Skin,” featuring voices from all three organizations. Missed the videos on social media? Watch the full series on the IPC YouTube channel.

WATCH NOW

Thursday, October 29, 2026

Introducing Take Two with IPC: Expert Talks in Two Minutes

Take Two with IPC gives a longer presentation a second life in two minutes. Each video takes an expert talk IPC has already published (a Take Ten recording or a symposium presentation) and condenses the clinical substance. The series launched this month alongside the World Psoriasis Day campaign with four videos on pediatric psoriasis: Psoriasis Look-Alikes and Anti-TNF-α Induced Skin Eruptions with IPC Board Member Amy Paller, MS, MD; Conventional Therapies with IPC Councilor Mona El-Kalioby, MBBCh, MSc, MD; and Phototherapy in Pediatric Psoriasis with Fernando Valenzuela, MD. New Take Two videos will be featured each month, drawn from the Take Ten with IPC library and recordings from IPC symposia, with a link to the full presentation for each.

WATCH NOW

Thursday, October 29, 2026

Videos Now Available from the Eczema and Psoriasis Research Incubator

Select presentations from the Eczema and Psoriasis Research Incubator: Cross-Disciplinary Innovation Forum, hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the 55th Annual European Society for Dermatological Research (ESDR) Meeting, are now available. Topics include disease endotypes, atopic dermatitis-psoriasis overlap, cardiovascular risk in psoriasis, and genetic susceptibility.

WATCH NOW

Monday, October 26, 2026

Sex Differences in Psoriasis

In this Take Ten with IPC video, Juul van den Reek and PhD candidate Liana Barenbrug discuss sex differences in psoriasis, why these distinctions matter, what current research tells us, and which areas should be prioritized in future psoriasis research.

WATCH NOW

Thursday, October 1, 2026